S Kano Selected Research

S Kano Research Topics

Disease

9	Malaria 06/2012 - 01/2000
6	Falciparum Malaria (Plasmodium falciparum Malaria) 09/2005 - 01/2000
5	Rheumatoid Arthritis 01/2019 - 06/2000
3	Colonic Neoplasms (Colon Cancer) 04/2016 - 05/2015
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 04/2000
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 12/2013
2	Lymphoma (Lymphomas) 05/2015 - 08/2000
2	Delirium 07/2000 - 02/2000
2	Hemorrhage 04/2000 - 01/2000
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Neoplasms (Cancer) 06/2015
1	Tay-Sachs Disease 01/2015
1	Maxillary Sinus Neoplasms 12/2013
1	Genomic Instability 10/2013
1	Carcinogenesis 10/2013
1	Carcinoma (Carcinomatosis) 10/2013
1	Schizophrenia (Dementia Praecox) 07/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2005
1	Body Weight (Weight, Body) 09/2004
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2003
1	Lung Diseases (Lung Disease) 01/2003
1	Atopic Dermatitis (Atopic Eczema) 08/2002
1	Hypocalcemia 06/2002
1	Muscular Diseases (Myopathy) 06/2002
1	Polymyositis 06/2002
1	Muscle Weakness 06/2002
1	Hyperphosphatemia 06/2002
1	Hemoglobinuria 09/2001
1	Anemia 09/2001
1	Communicable Diseases (Infectious Diseases) 04/2001
1	Seizures (Absence Seizure) 02/2001
1	Morphine Dependence 02/2001
1	Systemic Scleroderma (Systemic Sclerosis) 10/2000
1	Vascular Diseases (Vascular Disease) 10/2000
1	Dermatomyositis (Dermatopolymyositis) 10/2000
1	Cryoglobulinemia 08/2000
1	Paraproteinemias (Monoclonal Gammopathy) 08/2000
1	Hepatitis 08/2000
1	Dementia (Dementias) 07/2000
1	Hyperparathyroidism 07/2000
1	Necrosis 06/2000

Drug/Important Bio-Agent (IBA)

3	EnzymesIBA 01/2019 - 04/2001
3	ArtesunateIBA 09/2005 - 09/2001
3	artenimol (dihydroartemisinin)IBA 09/2005 - 06/2003
3	Immunoglobulin G (IgG)IBA 04/2001 - 03/2000
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2015
2	ImmunosorbentsIBA 01/2019 - 04/2001
2	Histones (Histone)IBA 06/2015 - 07/2013
2	Pharmaceutical PreparationsIBA 01/2015 - 09/2004
2	Indicators and Reagents (Reagents)IBA 06/2012 - 08/2000
2	artemisinin (artemisinine)IBA 06/2003 - 09/2001
2	CalciumIBA 06/2002 - 07/2000
2	PeroxiredoxinsIBA 08/2001 - 07/2000
2	AntibodiesIBA 04/2001 - 03/2000
2	Immunoglobulin M (IgM)IBA 04/2001 - 08/2000
2	Immunoglobulin A (IgA)IBA 04/2001 - 08/2000
2	Antimalarials (Antimalarial Agents)IBA 01/2001 - 03/2000
2	SteroidsIBA 06/2000 - 01/2000
2	AntigensIBA 04/2000 - 01/2000
1	KIR3DL1 ReceptorsIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	KIR ReceptorsIBA 01/2019
1	Green Fluorescent ProteinsIBA 01/2019
1	Deoxyglucose (2 Deoxy D glucose)IBA 12/2018
1	Nonsense Codon (Nonsense Mutation)IBA 04/2016
1	Protein Kinases (Protein Kinase)IBA 06/2015
1	RNA (Ribonucleic Acid)IBA 05/2015
1	Messenger RNA (mRNA)IBA 05/2015
1	G(M2) Ganglioside (Ganglioside GM2)IBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 12/2013
1	AminesIBA 10/2013
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 10/2013
1	Mefloquine (Lariam)FDA LinkGeneric 09/2005
1	piperaquineIBA 09/2005
1	Cholecalciferol (Vitamin D3)FDA Link 06/2005
1	maxacalcitolIBA 06/2005
1	Trimethoprim (Proloprim)FDA LinkGeneric 06/2003
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 06/2003
1	Vitamin A (Retinol)FDA LinkGeneric 04/2003
1	VitaminsIBA 04/2003
1	AntioxidantsIBA 04/2003
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 01/2003
1	CytokinesIBA 08/2002
1	Chemokine ReceptorsIBA 08/2002
1	CC ChemokinesIBA 08/2002
1	Parathyroid Hormone (Parathormone)IBA 06/2002
1	Creatine Kinase (Creatine Phosphokinase)IBA 06/2002
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2001
1	Immunodominant EpitopesIBA 04/2001
1	Chloroquine (Aralen)FDA LinkGeneric 03/2001
1	Morphine (MS Contin)FDA LinkGeneric 02/2001
1	CollagenIBA 10/2000
1	Rheumatoid FactorIBA 08/2000
1	LithiumIBA 07/2000
1	BismuthIBA 07/2000
1	Amyloidogenic ProteinsIBA 06/2000
1	bucillamine (SA 96)IBA 06/2000
1	Penicillamine (Cuprimine)FDA Link 06/2000

Therapy/Procedure

4	Therapeutics 06/2000 - 01/2000
1	Radiotherapy 12/2013